OncoGenex

OncoGenex is a leader in the development of novel therapeutics that target important mechanisms of treatment resistance in cancer. We are committed to the development and commercialization of first-in-class, innovative therapies that have the potential to redefine treatment outcomes for patients with a variety of cancers.
Company Growth (employees)
Type
Public
HQ
Bothell, US
Size (employees)
17 (est)-58%
OncoGenex is headquartered in Bothell, US

Key People at OncoGenex

Scott Cormack

Scott Cormack

President & Chief Executive Officer
David V. Smith

David V. Smith

Director

OncoGenex Office Locations

OncoGenex has offices in Bothell, Vancouver
Bothell, US (HQ)
201 19820 North Creek Pkwy
Vancouver, CA
400 1001 W Broadway

OncoGenex Metrics

OncoGenex Financial Metrics

Net income (2013)

($31.8 m)

Market capitalization (21-Mar-2017)

$15 m

Closing share price (21-Mar-2017)

$0.5

Cash (31-Dec-2016)

$15.2 m
OncoGenex's current market capitalization is $15 m.
FY, 2013

EBIT

($28.4 m)

Net Income

($31.8 m)
FY, 2013FY, 2014FY, 2015FY, 2016

Cash

$14.6 m$27.9 m$34.3 m$15.2 m

Accounts Receivable

$218 k$113 k$111 k$32 k

Inventories

Current Assets

$53.9 m$55.8 m$57.3 m$26.9 m

PP&E

$397 k$257 k$602 k$258 k

Total Assets

$55.7 m$56.3 m$58.2 m$27.5 m

Accounts Payable

$139 k$72 k$1.3 m$2.1 m

Current Liabilities

$14.9 m$22.2 m$20.7 m$8.5 m

Additional Paid-in Capital

$168.2 m$191.4 m$211.6 m$213.2 m

Retained Earnings

($133.7 m)($160 m)($176.8 m)($196.9 m)

Total Equity

$37.2 m$37.4 m$19 m

Financial Leverage

1.5 x1.6 x1.4 x
FY, 2013FY, 2014FY, 2015FY, 2016

Net Income

($31.8 m)($26.2 m)($16.8 m)($20.1 m)

Depreciation and Amortization

$227 k$223 k$244 k$188 k

Accounts Receivable

$109 k$105 k$2 k$79 k

Inventories

Accounts Payable

($1.2 m)($67 k)$1.3 m$778 k

Cash From Operating Activities

($35.9 m)($17.3 m)($9.1 m)($29.7 m)

Purchases of PP&E

($253 k)($82 k)($371 k)($46 k)

Cash From Investing Activities

$32.4 m$5.4 m($2.1 m)$10.6 m

Cash From Financing Activities

$10 k$25.2 m$17.6 m($2 k)

OncoGenex Market Value History

OncoGenex Online Presence

OncoGenex Company Life

You may also be interested in